SAB Biotherapeutics (SABS) Cash & Current Investments (2020 - 2026)
SAB Biotherapeutics (SABS) reported Cash & Current Investments of $102.63 million for Q2 2026, compared with $5.71 million a year earlier and down 4.4% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, SAB Biotherapeutics posted Cash & Current Investments of $96.59 million, up 365.3% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of 50.3% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $20.76 million in FY2024 (-63.3%), $56.57 million in FY2023 (+275.9%), $15.05 million in FY2022 (-54.7%) and $33.21 million in FY2021 (+163.3%).
- Five-year quarterly Cash & Current Investments spans a low of $2.43 million in Q3 2023 and a high of $110.88 million in Q3 2025.
- Year over year, Cash & Current Investments gained in three of the last six quarters, with growth averaging 191.1%.
- The high point for year-over-year Cash & Current Investments in five years was Q1 2026 (growth of 735.7%); the low point was Q2 2025 (a decline of 84.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $107.39 million (Q1 2026), $96.59 million (Q4 2025) and $110.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | SAB Biotherapeutics | 225.70 Mn | -191.80 Mn | - | 102.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 102.63 Mn |
| Mar 31, 2026 | 107.39 Mn |
| Dec 31, 2025 | 96.59 Mn |
| Sep 30, 2025 | 110.88 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 12.85 Mn |
| Dec 31, 2024 | 20.76 Mn |
| Sep 30, 2024 | 30.43 Mn |
| Jun 30, 2024 | 37.33 Mn |
| Mar 31, 2024 | 44.06 Mn |
| Dec 31, 2023 | 56.57 Mn |
| Sep 30, 2023 | 2.43 Mn |
| Jun 30, 2023 | 7.77 Mn |
| Mar 31, 2023 | 13.06 Mn |
| Dec 31, 2022 | 15.05 Mn |
| Sep 30, 2022 | 8.33 Mn |
| Jun 30, 2022 | 16.62 Mn |
| Mar 31, 2022 | 22.41 Mn |
| Dec 31, 2021 | 33.21 Mn |
| Sep 30, 2021 | 10.75 Mn |
API Access
SAB Biotherapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();